Rebct Ltd NI674967 false 2023-01-01 2023-12-31 2023-12-31 The principal activity of the company is medical practice Digita Accounts Production Advanced 6.30.9574.0 true NI674967 2023-01-01 2023-12-31 NI674967 2023-12-31 NI674967 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 NI674967 bus:Micro-entities 2023-01-01 2023-12-31 NI674967 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 NI674967 bus:FullAccounts 2023-01-01 2023-12-31 NI674967 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 NI674967 bus:Director1 2023-01-01 2023-12-31 NI674967 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 NI674967 countries:NorthernIreland 2023-01-01 2023-12-31 NI674967 2022-01-01 2022-12-31 NI674967 2022-12-31 NI674967 core:CurrentFinancialInstruments core:WithinOneYear 2022-12-31 iso4217:GBP xbrli:pure

Registration number: NI674967

Rebct Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 31 December 2023

 

Rebct Ltd

(Registration number: NI674967)
Balance Sheet as at 31 December 2023

2023
£

2022
£

Current assets

71,763

66,526

Creditors: Amounts falling due within one year

(27,508)

(34,058)

Total assets less current liabilities

44,255

32,468

Accruals and deferred income

(8,769)

-

 

35,486

32,468

Capital and reserves

35,486

32,468

1

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 0 (2022 - 4).

For the financial year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved and authorised by the director on 4 September 2024
 

.........................................
Doctor Ellen McKernan
Director